PATENT CLAIM ANALYSIS

Application Number: 16113574
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "482000"]

Abstract:
The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of treatment of diabetes, obesity, or an obesity associated disorder.

Claim (Index 10):
The pharmaceutical composition of  claim 1 , wherein the third composition is a second coating applied to a first coating comprising the second composition.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.51282
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15554449', '15058533', '15698115', '14379032', '14936963']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7654800562971306
- 35 USC 102 Novelty (BERT): 0.612482315602966
- Combined Prediction Score: 0.750180282227714
- Mean Citation Score: 411.937388
- Max Citation Score: 595.1677
- Similarity Product: 490.9896127910495

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test